TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.

Naomi B Haas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.